Riskpilot← Back to searchSign inGet full accessDr. Mouna AB
ABActiveOrg 5591389712Strandvägen 5 ABusiness and other management consultancy activities · NACE 7020Est. 20170 employees
Revenue 2025
SEK 88K
EBITDA margin
85.9%
+5885% vs 2024
Equity ratio
62.7%
Financial strength
Net profit 2025
SEK 54K
+4228% vs 2024
| Revenue | SEK 88K | — |
| EBITDA | SEK 75K | +5885% |
| Net profit | SEK 54K | +4228% |
| Total assets | SEK 127K | +382% |
| Equity | SEK 80K | +202% |
| Employees | 0 | — |
Legal name
Dr. Mouna AB
Org number
5591389712
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
12 december 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Ändamål för verksamheten är att bedriva konsultverksamhet samt förmedla kunskap inom hälsa, neurovetenskap, populärvetenskap, teknologi, filosofi, framtidstrender samt entreprenörskap och ledarskap, samt att bedriva produkt- och tjänsteutveckling inom ovanstående områden och att genom direkt eller indirekt delägarskap i andra bolag, köpa, sälja och belåna värdepapper och därmed förenlig verksamhet.
Address
Strandvägen 5 A
Email
info@doctormouna.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | — | 88 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −3 | −2 | −1 | 75 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −4 | −3 | −2 | −1 | 75 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −4 | −3 | −2 | −1 | 62 |
| Tax | −0 | — | — | — | −9 |
| Net profit | −4 | −3 | −2 | −1 | 54 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 35 | 31 | 28 | 26 | 127 |
| Equity | 32 | 30 | 28 | 26 | 80 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 2 | 2 | 0 | — | 35 |
| Total debt | 2 | 2 | — | — | 35 |
EBITDA margin
85.9%
This company
15.8%
Market median
+444% vs market
20212025
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20212025
Return on equity
66.9%
This company
18.4%
Market median
+264% vs market
20212025
Net profit margin
61.1%
This company
8.1%
Market median
+654% vs market
20212025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JE Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Mouna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Erik Noaksson | Audit | 0 companies |
| Seyd Nasrollah Esmaeil Zadeh | Deputy Board Member | 0 companies |
| Sara Abolhasani | Board of Directors | 0 companies |